Pulmonary lymphomatoid granulomatosis in acquired immunodeficiency syndrome: Lesions with epstein-barr virus infection

Keyphrases

• Age-matched 25%
• AIDS/HIV 100%
• Angioinvasion 25%
• Atypical Lymphocytes 25%
• Autopsy 50%
• B Cell Phenotype 25%
• B Cells 25%
• B-cell Neoplasms 25%
• CD20 25%
• CD20-negative 50%
• CD43 25%
• CD45RO 25%
• Cellular Origin 25%
• Co-expression 25%
• Consecutive Patients 25%
• Double Labeling 25%
• Epstein-Barr Virus 100%
• Epstein-Barr Virus Infections 100%
• Galveston 25%
• Gene Rearrangement 50%
• Heavy Chain 25%
• Histiocytes 25%
• HIV-negative 25%
• Immunohistochemical Staining 50%
• Immunophenotyping 25%
• In Situ Hybridization 50%
• Intermediate-size 25%
• Large Cell 25%
• Latent Membrane Protein 1 (LMP1) 25%
• Lung 50%
• Lymphocyte Cell 25%
• Lymphocytes 50%
• Lymphomatoid Granulomatosis 50%
• Microscopic Characteristics 25%
• Nucleus/nucleolus 25%
• Plasma Cells 25%
• Polymerase Chain Reaction 25%
• Prominent nucleoli 25%
• Pulmonary Lesions 50%
• Pulmonary Lymphomatoid Granulomatosis 100%
• RNA Fluorescence in Situ Hybridization (RNA-FISH) 25%
• Strong Association 25%
• Texas 25%
• Tumor Nodule 25%
• University of Texas 25%
• Zonal Necrosis 25%

Medicine and Dentistry

• Acquired Immune Deficiency Syndrome 100%
• B Cell 75%
• CD20 75%
• CD3 Antigen 25%
• Epstein Barr Virus 100%
• Epstein-Barr Virus Infection 100%
• Gene Rearrangement 50%
• Heavy Chain 25%
• Histiocyte 25%
• Human Immunodeficiency Virus 25%
• Identified Patient 25%
• Immunoglobulin Producing Cell 25%
• Immunophenotyping 25%
• In Situ Hybridization 75%
• Large Cell 25%
• Leukosialin 25%
• Lung 50%
• Lung Lesion 50%
• Lymphocyte 100%
• Lymphomatoid Granulomatosis 100%
• Membrane Protein 25%
• Necrosis 25%
• Neoplasm 50%
• Nucleolus 25%
• Polymerase Chain Reaction 25%